Discover 156 paid clinical trials in Manchester, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Lebanon NH, Saint Johnsbury VT, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Worcester MA, Lebanon NH, New Haven CT, New York NY,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Get alerts for new trials in your area by subscribing now
New
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Manchester NH, Concord NH, Lebanon NH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07393555
Phase 2, Recruiting
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
for
Advanced Cancer, Metastatic Cancer
Location: Manchester NH, Concord NH, New York NY, Spartanburg SC,
Sponsor: Alliance Foundation Trials, LLC.
Sex: All
Age: 21+
Code: NCT06963723
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Manchester NH, Concord NH, Burlington MA, Worcester MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for
Breast Cancer, HER2-positive Breast Cancer
Location: Manchester NH, Londonderry NH, Concord NH, Methuen MA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04893109
Phase 2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Manchester NH, Concord NH, Burlington MA, Peabody MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Manchester NH, Concord NH, Sanford ME, Lebanon NH,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer